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 CURRENTOPINION Organ procurement and preservation: what is new
and what is established?
Henrik Petrowsky
This section of Current Opinion in Organ Transplan-
tation addresses important issues in organ procure-
ment and preservation as well as optimal donor and
recipient management to minimize allograft injury
linked to organ preservation, ischemia and reperfu-
sion [1]. The mechanistic understanding of ische-
mia/reperfusion injury (IRI) has shifted during the
past two decades from a pure pathobiochemical
model to a two interrelated phase model of local
ischemic insult and innate inflammatory immune
response upon reperfusion. The better understand-
ing of immunological events during brain death in
deceased donors and after graft reperfusion is critical
to design immune-specific therapies to minimize
IRI. But also optimal donor management and anes-
thetic strategies during the transplant procedure
and early postoperative course are important
elements to protect allografts and improve outcome
of recipients.
The introduction of University of Wisconsin
solution in 1987 has revolutionized organ procure-
ment by safely increasing the duration of organ
preservation. The impact of University ofWisconsin
solution on organ procurement is probably compar-
able with the impact of cyclosporine on liver trans-
plantation. Parson and Guarrera [2] review the
current status of preservation solutions for static
cold storage. Although other effective preservation
solutions, such as histidine–tryptophan–ketogluta-
rate, Celsior, and Institute George Lopez-1, have
been developed and successfully used in visceral
multiorgan procurement, University of Wisconsin
solution remains the most popular preservation
solution for kidney, liver, pancreas and intestine
procurement today. A recently published meta-
analysis demonstrated that there is currently no
evidence of the superiority of one preservation
solution over another in terms of post-transplant
outcome [3].
Another topic of the journal section was ‘Where
to cannulate and how to perfuse’ during multiorgan
procurement [4]. There are two types of vascular
access for abdominal organ flushing: cannulation
of the arterial system only (infrarenal aorta, iliac
artery) or dual cannulation of arterial and venous
(inferior mesenteric vein) system. Although the
dual-flush technique appears to provide a more
complete organ flush especially for liver and pan-
creas, there is currently no evidence on the superi-
ority of dual over single flush. Surprisingly, only
one randomized trial exists comparing both flush
techniques [5]. But also, high-level evidence data on
perfusion pressure, flow and volumes are currently
not available in the literature. This emphasizes the
need for additional large randomized trials in this
area of organ procurement.
Optimal donor treatment before procurement is
essential for conditioning of the donor to achieve
the best possible donor organ protection before
procurement. McKeown and Ball [6] review this
important topic from the anesthesiologic and
neurologic point of view. The early identification
of potential donors allows early optimal donor
management (ODM) so that the greatest number
of organs can be procured and transplanted. One
important element of ODM is hormonal resuscita-
tion with thyroid supplementation for cardiovascu-
lar stability, steroid administration for anti-
inflammatory treatment of brain death-mediated
immune inflammatory events, and vasopressin for
cardiovascular support and prevention of excessive
fluid overload. The review provides catastrophic
brain injury guidelines, which should be used to
guide ODM tominimize the pre-preservation injury.
Brain death triggers immune inflammatory
events that have negative effects on donor organs
before procurement and after reperfusion at
allograft implantation. Dziodzio et al. [7] review
immune inflammatory mechanisms of brain
death on IRI and highlight the potential role of
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immunosuppressive treatment in donors to target
brain death-mediated proinflammatory organ
injury. The deceased donor treatment with methyl-
prednisolone [8], which is an essential element of
ODM as reported by McKeown and Ball in this
section [6], results in less IRI injury and decreases
the incidence of acute rejection. There is growing
evidence that inflammatory innate immune acti-
vation is a key player in the establishment of IRI
after reperfusion. This type of sterile immune
response is triggered by the sentinel pattern recog-
nition receptor system [1]. There is growing evi-
dence that T cells in particular CD4þ are involved
in the activation and regulation of the inflam-
matory immune response to IRI. This topic is high-
lighted in the review by Rao et al. [9]. The authors
of this review state that a better understanding of
T-cell biology in IRI is important for the develop-
ment of T cell-specific treatments to ameliorate IRI.
Organ protection does not only apply to the
donor, procurement and preservation but also to
anesthetic strategies during and after the operation.
Hovaguiman et al. [10] present a comprehensive
review on this topic from the anesthesiologic point
of view. The authors conducted a systematic review
of the current literature of the years 2012 and
2013. Postoperative pain control, early extubation,
adequate blood glucose control and strategies to
reduce perioperative bleeding are associated with
improved posttransplant outcome. Volatile anes-
thesia with seroflurane or inhaled nitric oxide are
promising protective strategies against IRI directly
before, during and after reperfusion of the allograft.
The benefit of these anesthesiologic treatment strat-
egies during transplantation is currently tested in
randomized controlled trials.
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